Advisory - Herberex may pose serious health risks; Health Canada suspends product licence
OTTAWA, ON, Dec. 31, 2021 /CNW/ -
Summary
Product: Herberex (NPN 80029339), advertised as a herbal product for sexual enhancement.
Issue: Health Canada testing found an undeclared drug ingredient similar to a prescription drug used for erectile dysfunction. The ingredient is not listed on the product label and may pose serious health risks.
What to do: Do not use this product. Consult a health care professional if you have used this product and have health concerns.
Issue Health Canada is warning consumers not to use Herberex, advertised as an herbal product for sexual enhancement, because it may pose serious health risks. Herberex was authorized as a natural health product, but Health Canada testing found the product contains nortadalafil.
Nortadalafil is an unauthorized ingredient that is similar to tadalafil, which is a prescription erectile dysfunction drug that should only be used under the supervision of a health care professional. Nortadalafil may pose similar health risks as tadalafil. Individuals taking any kind of nitrate drug (e.g., nitroglycerine) should not take drugs like tadalafil as the interaction can cause potentially life-threatening low blood pressure. Individuals with heart problems are at increased risk of cardiovascular side effects such as heart attack, stroke, chest pain, high blood pressure and abnormal heartbeat. Other possible side effects include headache, facial flushing, indigestion, dizziness, abnormal vision, and hearing loss.
Health Canada has suspended the product licence for Herberex (NPN 80029339) given the health risks posed by the product. It is illegal for any person or company to sell this product in Canada.
Sinvention Boutique, 390 Douro St Studio 5, Stratford, ON
One Stop Love Shop, 44310 Yale Road, Unit 2, Chilliwack, B.C.
One Stop Love Shop, 109 - 32883 South Fraser Way, Abbotsford, B.C.
The Department is working with the Canada Border Services Agency to help prevent further importation of Herberex. If any new health risks are identified, Health Canada will take action and inform Canadians as needed.
Affected products
Product
Company
NPN
Herberex
Nutraloid Labs Inc.
80029339 (suspended)
What you should do
Do not use Herberex. Consult a health care professional if you have taken this product and have health concerns.
Genexine (KOSDAQ: 095700), a publicly-listed, clinical-stage Korean biopharmaceutical company committed to the discovery and development of novel biologics for the treatment of serious unmet medical needs, announced a merger with EPD Biotherapeutics...
The IAMStm brand, proudly part of the Mars family of brands, announced today the launch of the IAMStm Puppy Hub and Kitten Hub, two online tools featuring expert knowledge and advice for new and soon-to-be pet parents. Each Hub will bring...
Today, TELUS Health announced a collaboration with Nova Scotia Health (NSH) to enable residents of Nova Scotia to access their primary care information through the YourHealthNS app. This health data interoperability initiative marks the first...
The global Digital Healthcare Market, valued at $220.10 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $836.10 billion by 2031, growing at a compound annual growth rate (CAGR) of 21% from 2024 to...
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period.
The...
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...